In addition, prolonged hypoxia can lead to therapeutic resistance (i.e., sorafenib treatment) can further induce the HIF-1α and NF-κB signalling, promoting a more aggressive and treatment resistant tumour behaviour [228]. The gene discussed is HIF1A; the disease is neoplasm.